Allakos Inc. — Form D/A
Allakos Inc. of SAN CARLOS, CA, a company, filed a Form D amendment with the SEC on 2015-03-25. The offering totals $47.0M, of which $27.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-03-25
- Form: D/A
- Accession: 0001564824-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $47.0M
- Amount sold: $27.9M
- Remaining: $19.1M
- Investors: 12
- Date of first sale: 2012-12-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-188692
Issuer
- Name: Allakos Inc.
- CIK: 0001564824
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 75 SHOREWAY ROAD, SUITE A, SAN CARLOS, CA, 94070
- Phone: 6505975002
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Christopher Bebbington | Director | San Carlos, CA |
| Farah Champsi | Director | San Carlos, CA |
| Peter Moldt | Director | Seattle, WA |
| Christopher Bebbington | Executive Officer | San Carlos, CA |
| Alejandro Dorenbaum | Executive Officer | San Carlos, CA |
| Nenad Tomasevic | Executive Officer | Beaverton, OR |
| Paul Walker | Director | New York, NY |
| Dan Janney | Director | Watertown, MA |
| Robert Alexander | Director | Boston, MA |
| Robert Alexander | Executive Officer | Boston, MA |
| John McKearn | Director | Seattle, WA |
| Adam Tomasi | Executive Officer | NEW YORK, NY |
| Steve James | Director | SAN CARLOS, CA |
Other filings by this issuer (3)
More